Vaxil Bio Ltd.

Vaxil Bio Ltd.verified

VXL.V

Price:

$0.14

Market Cap:

$383.54K

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its abi...[Read more]

Industry

Biotechnology

IPO Date

2010-03-30

Stock Exchange

TSXV

Ticker

VXL.V

The Enterprise Value as of December 2025 (TTM) for Vaxil Bio Ltd. (VXL.V) is 36.54K

According to Vaxil Bio Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 36.54K. This represents a change of -99.88% compared to the average of 30.87M of the last 4 quarters.

Vaxil Bio Ltd. (VXL.V) Historical Enterprise Value (quarterly & annually)

How has VXL.V Enterprise Value performed in the past?

The mean historical Enterprise Value of Vaxil Bio Ltd. over the last ten years is 313.31M. The current 36.54K Enterprise Value has changed -98.83% with respect to the historical average. Over the past ten years (40 quarters), VXL.V's Enterprise Value was at its highest in in the December 2020 quarter at 1.56B. The Enterprise Value was at its lowest in in the June 2025 quarter at 200.92K.

Quarterly (TTM)
Annual

Average

313.31M

Median

162.94M

Minimum

27.63M

Maximum

1.52B

Vaxil Bio Ltd. (VXL.V) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vaxil Bio Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 880.04%

Maximum Annual Enterprise Value = 1.52B

Minimum Annual Increase = -83.78%

Minimum Annual Enterprise Value = 27.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202427.63M-83.78%
2023170.31M25.72%
2022135.47M-73.34%
2021508.14M-66.67%
20201.52B880.04%
2019155.56M22.53%
2018126.96M-43.95%
2017226.51M15.54%
2016196.05M216.74%
201561.90M187.30%

Vaxil Bio Ltd. (VXL.V) Average Enterprise Value

How has VXL.V Enterprise Value performed in the past?

The current Enterprise Value of Vaxil Bio Ltd. (VXL.V) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

111.14M

5-year avg

473.22M

10-year avg

313.31M

Vaxil Bio Ltd. (VXL.V) Enterprise Value vs. Peers

How is VXL.V’s Enterprise Value compared to its peers?

Vaxil Bio Ltd.’s Enterprise Value is less than Global Health Clinics Ltd. (2.37M), less than Optimind Pharma Corp. (538.80K), less than CENTR Brands Corp. (444.81K), less than TripSitter Clinic Ltd. (730.29K), less than Greenrise Global Brands Inc. (2.82M), less than Steep Hill Inc. (833.81K), less than Vibe Growth Corporation (2.03M), less than Entheon Biomedical Corp. (795.80K), less than Doseology Sciences Inc. (2.51M), less than Universal Ibogaine Inc. (3.95M),

Build a custom stock screener for Vaxil Bio Ltd. (VXL.V) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxil Bio Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaxil Bio Ltd. (VXL.V) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaxil Bio Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Vaxil Bio Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Vaxil Bio Ltd. (VXL.V)?

What is the 3-year average Enterprise Value for Vaxil Bio Ltd. (VXL.V)?

What is the 5-year average Enterprise Value for Vaxil Bio Ltd. (VXL.V)?

How does the current Enterprise Value for Vaxil Bio Ltd. (VXL.V) compare to its historical average?